Katharine E. Spink, VP and Chief Operating Officer at Asterias Biotherapeutics, Inc. (AST), sold 3,760 shares at $6.00 ($23K) on 2015-09-15, disclosed to the SEC on 2015-09-16.
Scheduled sale ($23k) by VP and Chief Operating Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| AST | SELL | 2016-11-28 | $14K | — | Filing → |
| AST | SELL | 2016-11-21 | $13K | — | Filing → |
| AST | SELL | 2016-10-11 | $39K | — | Filing → |